Get started
VERTEX PHARMACEUTICAL COM STK USD0.01VERTEX PHARMACEUTICAL COM STK USD0.01VERTEX PHARMACEUTICAL COM STK USD0.01

VERTEX PHARMACEUTICAL COM STK USD0.01

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

0QZU trade ideas

VRTX Gap Fill Play - Bullish- Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. - Target Price: $292.00 by CreditSuisse Oct 29, 2020 with multiple buy ratings by different analysts - Recent Drop from failed study of VX-814 for patients with ALPHA-1 ANTITRYPSIN DEFICIENCY, but still one more study going in same target area and fundamentals of other revenue makers intact. - Price entering the gap from that day's drop. - Trends of more insider buying since the drop and stock buy backs. Signaling that the stock is undervalued. - Bull flagging right under the gap. Key Level: $232.41 Price Target: 269.93 ATR: $6.60 Play: Bullish Gap Fill Buy the Dip under the key level to scale in Use $232.41 as inflection point. Look for breakout with increased volume Price Target: 270 Under $224 will invalidate
NASDAQ:VRTXLong
by Pr0diJ
VRTX Buy at 285.67 with profit taking at 382.73VRTX is basing below the 10WMA and that is a big negative. The positive of this is that the volume action below the 10WMA is drying up, which means that there is a quiet consolidation period that is going on. If this consolidation period starts to show price action that shoots above the 10WMA then there is a potential buy. The 1st buy might be at 285.67 with the 2nd one at 306.18 assuming they are both confirmed by high volume action. VRTX can break out at any point because the minimum 5 weeks for a base has been met. Fundamentals are great as shown below. Yearly EPS 2018: 4.08 2019: 5.33 2020: 9.72 2021: 11.26 Quarterly Sales Sep-19: +21% Dec-19: +62% Mar-20: +76% Jun-20: +62%
NASDAQ:VRTXLong
by HaleyZhao